Conferences and symposiums Conference: Frontiers in Cancer Research and Therapy 2026
20-03-2026 3:45 pm Add to iCal

Welcome to the annual Frontiers in Cancer Research and Therapy conference, arranged by the Department of Oncology-Pathology. The program spans from basic cancer biology to AI‑driven computational oncology, precision medicine, immunotherapy, clinical translation, and includes a dedicated session on childhood cancer.
The conference is now fully booked, but you can sign up for the waitlist.
Programme
Session 1: Tumor biology
Moderators: Susanne Schlisio and Brinton Seashore-Ludlow, Department of Oncology-Pathology, Karolinska Institutet
08.55: Welcome, Ola Larsson, Head of Department, Department of Oncology-Pathology
09.00 – Identifying the epigenetic modulators, modifiers, and mediators of human pancreatic cancer metastasis
Andrew Feinberg, Johns Hopkins University
09.30 – New insights into genome instability and replication stress in cancer: Mechanisms and therapeutic opportunities
Jiri Bartek, Danish Cancer Institute
10.00 – Coffee Break
Session 2: Novel treatment strategies
Moderators: Brinton Seashore-Ludlow and Per Hydbring, Department of Oncology-Pathology, Karolinska Institutet
10.30 – Developing a Clinically Viable MYC Inhibitor: to Boldly Go Where No One Has Gone Before
Laura Soucek, Vall d'Hebron Institute of Oncology
11.00 – Novel strategies to targeting drug-tolerant persister state in lung cancer
Pasi Jänne, Dana-Farber Cancer Institute
11.30 – Targeting cancer-relevant 14-3-3 protein complexes with molecular glues
Christian Ottmann, Eindhoven University of Technology
12.00 – Novel therapeutic strategies against pancreatic cancer
Mariano Barbacid, CNIO
Lunch and Poster session
Session 3: Digital pathology and AI
Moderators: Per Hydbring and Lukas Orre, Department of Oncology-Pathology, Karolinska Institutet
14.00 – Multimodal and Temporal All-of-Patient Foundation Models for Oncology
Faisal Mahmood, Harvard Medical School
14.30 – Artificial Intelligence-based precision pathology: scalable phenotyping and clinical precision diagnostics for breast cancer
Mattias Rantalainen, Karolinska Institutet
15.00 – Decoding and Translating the Languages of Cancer
Jian Shu, Harvard Medical School
15.30 – Coffee Break
16.00 – A trusted partner in patient-centred cancer research - since 1910
Magdalena Nilsson, General Secretary, the Cancer Research Funds of Radiumhemmet (Radiumhemmets Forskningsfonder)
16.15 –"Dan Grander Award 2025", Mats Marshall Heyman presents the winner Niek van Bree, “Development of translational models and identification of novel therapeutic targets for medulloblastoma”
16.50 – End of day 1
Ola Larsson, Head of Department
Session 4: Advances in Immunotherapy
Moderators: Hanna Eriksson and Lukas Orre, Department of Oncology-Pathology, Karolinska Institutet
09:00 – Reaching beyond checkpoint inhibitors to defeat metastatic melanoma by immunotherapy
Inge Marie Svane, Copenhagen University Hospital, Herlev
09:30 – Optimising CAR‑T cells for improved efficacy and reduced toxicity
Magnus Essand, Uppsala University
10:00 – Personalized T-cell therapies for the treatment of solid cancers
Alena Gros, Vall d’Hebron Institute of Oncology
10:30 – Coffee Break
Session 5: Tackling childhood cancer
Moderators: Susanne Schlisio and Brinton Seashore-Ludlow, Department of Oncology-Pathology, Karolinska Institutet
10:50 – A look back at the nursery of tumors in children
Stefan Pfister, Hopp Children’s Cancer Center
11:30 – Advances in Neuroblastoma Therapy through the Beat Childhood Cancer Consortium
Giselle Saulnier Sholler, Penn State Health
Lunch and Poster session
Session 5 (continued): Tackling Childhood Cancer
13:30 – BraAInchild: building an integrated data ecosystem for childhood cancer
David Gisselson, Lund University
14:00 – Insights into neuroblastoma pathogenesis and clinical implications
Matthias Fischer, University of Cologne
Closing session - Early clinical trials
Moderator: Simon Ekman, Department of Oncology-Pathology, Karolinska Institutet
14:30 – Challenges of drug discovery in thoracic oncology
Benjamin Besse, Institut Gustave Roussy
15:00 – Best poster 2026, presentation of the winner
15:20 – Ola Larsson, Head of Department, conclusions
